Lilly joins Alexion, Astrazeneca, ATS Life Sciences – Scientific Products, Glaxosmithkline, Genentech, Janssen, Roquette, and Sanofi on the CPPR Industrial Advisory Board. We look forward to Lilly’s participation in our quest to advance pharmaceutical processing. The funds that Lilly has committed to CPPR research are pooled with those of the other member companies. The funds support rigorous academic research into industrially relevant pharmaceutical processing research at the CPPR academic sites, with mentorship from representatives from CPPR companies.